Liposome-Encapsulated Tobramycin and IDR-1018 Peptide Mediated Biofilm Disruption and Enhanced Antimicrobial Activity against <i>Pseudomonas aeruginosa</i>

Liposome-Encapsulated Tobramycin and IDR-1018 Peptide Mediated Biofilm Disruption and Enhanced Antimicrobial Activity against <i>Pseudomonas aeruginosa</i>

The inadequate eradication of pulmonary infections and chronic inflammation are significant complications in cystic fibrosis (CF) patients, who usually suffer from persistent and frequent lung infections caused by several pathogens, particularly <i>Pseudomonas aeruginosa</i> (<i>P....

Full description

Bibliographic Details
Main Authors: Nouf M. Alzahrani, Rayan Y. Booq, Ahmad M. Aldossary, Abrar A. Bakr, Fahad A. Almughem, Ahmed J. Alfahad, Wijdan K. Alsharif, Somayah J. Jarallah, Waleed S. Alharbi, Samar A. Alsudir, Essam J. Alyamani, Essam A. Tawfik, Abdullah A. Alshehri
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Pharmaceutics
Subjects:
cystic fibrosis
liposomes
tobramycin
innate defense regulator peptide-1018 (IDR-1018)
biofilm
<i>Pseudomonas aeruginosa</i>
Online Access:https://www.mdpi.com/1999-4923/14/5/960

Similar Items

Similar Items